Bio-Techne shareholders approve its sale to Merck KGaA
The US antitrust waiting period has expired, and the deal is expected to close by late 2026 or early 2027.
The US antitrust waiting period has expired, and the deal is expected to close by late 2026 or early 2027.
Intelligence
Activity